MedPath

Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial

Phase 2
Completed
Conditions
Arthritis Knee
Arthritis of Hip
Interventions
Registration Number
NCT04441112
Lead Sponsor
Saint Alphonsus Regional Medical Center
Brief Summary

Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) injections may offer a safer profile due to their differing mechanism of action; however, there is a relative dearth of information regarding their efficacy. This non-inferiority study compares the effectiveness of triamcinolone versus ketorolac in treating symptoms of moderate to advanced primary osteoarthritis of the hip and knee.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Symptomatic, radiographically proven degenerative joint disease in the hip or knee
Exclusion Criteria
  • recent injection in the hip or knee within the previous 3 months
  • history of traumatic osteoarthritis or ligamentous reconstruction
  • chronic narcotic use
  • history of inflammatory or neuropathic arthropathy
  • pregnant and/or nursing women
  • allergy or strong reaction to study medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ketorolac Intraarticular Hip InjectionKetorolac Intraarticular InjectionPatients will receive an intraarticular hip injection with ketorolac.
Triamcinolone Intraarticular Hip InjectionTriamcinolone Intraarticular InjectionPatients will receive an intraarticular hip injection with triamcinolone.
Ketorolac Intraarticular Knee InjectionKetorolac Intraarticular InjectionPatients will receive an intraarticular knee injection with ketorolac.
Triamcinolone Intraarticular Knee InjectionTriamcinolone Intraarticular InjectionPatients will receive an intraarticular knee injection with triamcinolone.
Primary Outcome Measures
NameTimeMethod
Change in Visual Analogue Scale (Baseline to One Week Post-injection)Comparing baseline to one week post-injection

Pain Score

Change in PROMIS Global Health Scores (Baseline to One Month Post-injection)Comparing baseline to one month post-injection

Overall patient wellbeing

Change in Visual Analogue Scale (Baseline to One Month Post-injection)Comparing baseline to one month post-injection

Pain Score

Change in Visual Analogue Scale (Baseline to Three Months Post-injection)Comparing baseline to three months post-injection

Pain Score

Change in PROMIS Global Health Scores (Baseline to One Week Post-injection)Comparing baseline to one week post-injection

Overall patient wellbeing

Change in PROMIS Global Health Scores (Baseline to Three Months Post-injection)Comparing baseline to three months post-injection

Overall patient wellbeing

Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Week Post-injection)Comparing baseline to one week post-injection

Functionality and pain of affected knee

Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Month Post-injection)Comparing baseline to one month post-injection

Functionality and pain of affected knee

Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to Three Months Post-injection)Comparing baseline to three months post-injection

Functionality and pain of affected knee

Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Week Post-injection)Comparing baseline to one week post-injection

Functionality and pain of affected hip

Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Month Post-injection)Comparing baseline to one month post-injection

Functionality and pain of affected hip

Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to Three Months Post-injection)Comparing baseline to three months post-injection

Functionality and pain of affected hip

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saint Alphonsus Regional Medical Center

🇺🇸

Boise, Idaho, United States

© Copyright 2025. All Rights Reserved by MedPath